About Us

About Us

Of the approximately 73 million induced abortions that took place between 2015 and 2019, an estimated 24 million were unsafe. In line with current scientific data and the World Health Organization’s recommendations, Linepharma International aims to make safe abortion and sexual and reproductive healthcare accessible to as many people as possible, in as many places as possible, regardless of their social, political, or economic circumstances.

Primarily through partnerships with local distribution partners, we have commercialized mifeprostone in over 25 countries worldwide. Initiatlly a Euro-centric commercial focus, we now focus on expanding the access to safe medication abortion and sexual and reproductive healthcare services and tools to the more broad international market.

2010

Since this year, Linepharma International has been providing high-quality non-surgical abortion products that meet the most rigorous regulatory health standards to patients and healthcare providers worldwide.

2014

After introducing a single-packed mifepristone in 2012, Australia became the first country to approve our co-packaged mifepristone and misoprostol product for the purposes of terminating a developing intrauterine pregnancy.

2015

Canada became the second country to approve the co-packaged presentation of mifepristone and misoprostol.

2023

Japon become the third country to approve the co-packaged presentation of mifepristone and misoprostol.

In the years since, we have succesfully introduced mifepristone and misoprostol products for medication abortion in various countries throughout Asia and Latin America in partnership with local distributors while establishing full-scale pharmaceutical operations teams in key markets in Canada and Japan.

Linepharma International is headquartered in London, United Kingdom,and operates affiliate offices in Toronto, Canada, and Tokyo, Japan.

OUR VALUES

linepharma-about-us-access-icon

Access

 

We are dedicated to expanding sexual and reproductive health services and tools in new markets internationally while supporting their growth in existing markets.

linepharma-about-us-safety-icon

Safety

 

We follow the most current scientific data and World Health Organization recommendations.

linepharma-about-us-support-icon

Support

 

We strive to improve patients’ and providers’ ability to access sexual and reproductive healthcare management tools.

linepharma-about-us-innovation-icon

Innovation

 

We are responsible for the world’s first co-packaged mifepristone and misoprostol developed specifically for medication abortion.

linepharma-about-us-quality-icon

Quality

 

Products manufactured in Europe and approved by some of the most stringent health authorities.

OUR PARTNERS

Linepharma’s medication abortion products are approved by the world’s most stringent regulatory health authorities.

Our relationships with local distributors and non-governmental organizations in Australia, Canada, and parts of Asia and Latin America help bring medication abortion products to as many communities as possible.

Is medication abortion available in your country? If you’re a pharmaceutical distributor in the Americas or Asia-Pacific who may be interested in distributing Linepharma’s products, contact us today Contact page.

Australia: Marie Stopes Health (MSI Australia)

https://www.mshealth.com.au/


Colombia: Profamilia

https://profamilia.org.co/


Mongolia: MSICC (MSI Mongolia)

https://mariestopes.org/where-we-work/mongolia/

Mexico: Marie Stopes Mexico

https://mariestopes.org.mx/


South Korea: Hyundai Pharm

http://www.hyundaipharm.co.kr/

Tunisia

 


Bolivia: Tecnologías en Salud

https://www.tes.com.bo/


Chile: APROFA Chile

https://www.aprofa.cl


Our Canadian affiliates:
Linepharma International Inc Canada.
402-21 St Clair Avenue East
Toronto, ON M4T 1L9
Canada

https://www.linepharma.ca/


Our Japanese affiliates:
Linepharma Japan
ARK Mori Building 12th Floor
1-12-32 Akasaka, Minato-ku,
Tokyo, 107-6012
Japan

https://www.linepharma.co.jp


Our headquarter:
Linepharma International Ltd.
16 Upper Woburn Place
London
WC1H 0BS
United Kingdom